Jan 18, 2021 07:41AM
Jan 4, 2021 09:40AM
Dec 10, 2020 08:18AM
Nov 11, 2020 07:25AM
Nov 9, 2020 07:30AM
Oct 27, 2020 08:03AM
Oct 27, 2020 08:03AM Kitov Pharma Receives Notice of Allowance for a U.S. Patent Covering its Anti-Cancer Drug Candidate, NT219
Oct 16, 2020 07:33AM
Oct 16, 2020 07:21AM
Sep 8, 2020 07:14AM
Sep 8, 2020 07:10AM
Sep 4, 2020 08:01AM
Sep 4, 2020 08:00AM
Aug 12, 2020 04:55PM Kitov Pharma Announces ADS Ratio Change
Aug 11, 2020 07:15AM
Jul 9, 2020 07:33AM
Jul 9, 2020 07:30AM
Jul 8, 2020 07:30AM
Jul 8, 2020 07:30AM
Jul 2, 2020 08:47AM
Jul 2, 2020 08:34AM Kitov Pharma Issues CEO Shareholder Letter Providing Business Update
Jun 25, 2020 04:30PM
Jun 23, 2020 01:21PM
Jun 23, 2020 01:20PM
May 22, 2020 07:01AM
May 22, 2020 07:00AM
May 20, 2020 07:30AM
May 19, 2020 08:05AM Kitov to Present Preclinical Data on NT219 at American Association of Cancer Research Virtual Annual Meeting II
May 14, 2020 07:10AM
May 8, 2020 04:00PM
May 6, 2020 08:04AM
May 6, 2020 08:00AM
Apr 20, 2020 08:05AM
Mar 17, 2020 08:00AM
Mar 12, 2020 08:15AM Kitov Pharma Provides Update on Planned U.S. Launch of Consensi™ and Provides Three-Year Revenue Forecast
Mar 12, 2020 08:01AM
Mar 12, 2020 08:00AM
Feb 24, 2020 09:00AM
Feb 11, 2020 07:00AM
Feb 3, 2020 08:21AM
Feb 3, 2020 08:20AM
Feb 3, 2020 08:20AM Kitov Pharma Receives Issue Notification for a U.S. Patent Covering its anti-CEACAM1 Cancer Drug, CM-24
Jan 24, 2020 08:11AM
Jan 24, 2020 08:10AM
Jan 9, 2020 08:35AM
Jan 9, 2020 08:35AM
Jan 8, 2020 07:30AM
Jan 8, 2020 07:00AM
Oct 11, 2019 08:55AM Kitov Pharma (KTOV) Announces Amended Marketing and Distribution Agreement with Coeptis, Provides Update on Launch of Consensi in U.S
Oct 11, 2019 08:54AM

325,297 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All